Promedius Redefines Osteoporosis Diagnosis with AI: Pioneering Korean Startup Advances Healthcare Innovation Globally

Promedius, a pioneering Korean startup in AI medical diagnostics, is making noteworthy strides in healthcare. Initially spanning various applications, the company now concentrates on osteoporosis, utilizing AI for triaging patients through chest X-ray images.

Traditionally, DXA tests have been the gold standard for osteoporosis, hindered by limited accessibility. With osteoporosis often asymptomatic, cases are typically diagnosed post-fracture. Promedius’ solution changes this, enabling early DXA testing for individuals flagged by the AI triage system, ensuring timely diagnosis.

Addressing healthcare disparities, Promedius commits to providing AI technologies to primary care clinics. By focusing on X-ray imaging, the company aims to bridge medical resource gaps, enhancing healthcare outcomes.

Actively pursuing global partnerships, Promedius collaborates with major DXA equipment manufacturers and global pharmaceutical companies specializing in osteoporosis treatments. Aligned with industry leaders, Promedius aims to advance its osteoporosis solution and expand globally.

With $2 million in prior funding from investors like The Big Bang Angels and Korea Credit Guarantee Fund, Promedius seeks an additional $10 million for growth. Dr. Hyun-Jin Bae, a Ph.D. expert in image processing and data analysis, anchors the company, propelling its trajectory.

Amidst rising global demand for precise medical diagnostics, Promedius, with its AI-driven osteoporosis analysis, leads in innovation. Through a comprehensive imaging modality approach, strategic partnerships, and a visionary roadmap, Promedius is set to significantly impact healthcare, enhancing patient care worldwide.

Also Read,

• Hyundai’s Asan Nanum Foundation’s “Asan Voyager” Program Propels Korean Startups into Global Markets
• How Emile Ferreira CEO, InsiteBot Can Help You Wow Your Customers While You Sleep?
• Health, wellness platform MindFi raises $2m to accelerate AI-driven products
• SG healthtech startup Mito Health scores $1.3m in fresh funding